Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine

Exposure to ionizing radiation increases the risk of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN), but such risks are not known in well-differentiated thyroid cancer (WDTC) patients treated with radioactive iodine (RAI). A total of 148 215 WDTC patients were identified from...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2018-04, Vol.32 (4), p.952-959
Hauptverfasser:	Molenaar, R J, Pleyer, C, Radivoyevitch, T, Sidana, S, Godley, A, Advani, A S, Gerds, A T, Carraway, H E, Kalaycio, M, Nazha, A, Adelstein, D J, Nasr, C, Angelini, D, Maciejewski, J P, Majhail, N, Sekeres, M A, Mukherjee, S
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1990/1673 631/67/1990/2331 631/67/2324 692/308/174 692/499 Cancer Cancer Research Care and treatment Chronic myeloid leukemia Complications and side effects Confidence intervals Critical Care Medicine Epidemiology Health aspects Health risk assessment Hematology Intensive Internal Medicine Iodine Iodine radioisotopes Ionizing radiation Latency Medicine Medicine & Public Health Myelodysplastic syndrome Neoplasms Oncology original-article Patients Prognosis Radioiodine Radiotherapy Regional development Risk assessment Risk factors Survival Thyroid Thyroid cancer Thyroidectomy Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!